How to reconstitute Ipamorelin: mixing and storage

An experimental peptide that triggers growth hormone release.

Also called: NNC 26-0161, NNC-26-0161.

Growth hormone secretagogues (ghrelin receptor) · Ghrelin receptor agonist and growth hormone secretagogue.

Comes as: Lyophilized powder vial reported online, Trial-controlled IV infusion, Nasal spray reported in analytical studies and adverse reports.

Mixed with: Community reports use bacteriostatic water; this does not establish compatibility or sterility..

Common vial sizes: 5 mg. Common water amounts: 2 mL.

5 mg with 2 mL is one community report, not a label instruction.
Syringe units mark volume, not peptide potency. Do not confuse mcg with mg.
Bacteriostatic water does not sterilize contaminated powder or prove a stored mixture remains sterile.

Before mixing: Community storage varies; no validated shelf life for unregulated ipamorelin vials was found.

After mixing: Users report refrigeration. No validated multiweek stability or sterility period was found.

Related to Ipamorelin

MK-677 (ibutamoren): This experimental oral drug raises growth hormone and IGF-1; risks include high blood sugar and swelling.
GHRP-2: A peptide that releases growth hormone and can increase hunger.
GHRP-6: A peptide studied in growth hormone tests and an experimental stroke combination.
Hexarelin: A peptide that releases growth hormone; repeated use can weaken the response.
Tirzepatide: A weekly GIP/GLP-1 injection with strong diabetes and weight-loss evidence and common stomach side effects.
BPC-157: An experimental repair peptide with mostly animal evidence and a few small human reports.

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.